(Q59066536)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29950727%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

title

IL-23 secreted by myeloid cells drives castration-resistant prostate cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29950727%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29950727%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Clarissa Spataro

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29950727%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Elena Zagato

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29950727%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Mateus Crespo

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29950727%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Emiliano Pasquini

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29950727%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Roberta Lucianò

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29950727%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Adam Sharp

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29950727%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Andrea Alimonti

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29950727%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

26

Johann de Bono

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29950727%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

author name string

Diletta Di Mitri

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29950727%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Veronica Gil

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29950727%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Gaston De Bernardis

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29950727%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Marco Losa

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29950727%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Michela Mirenda

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29950727%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Andrea Rinaldi

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29950727%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Semini Sumanasuriya

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29950727%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Antje Neeb

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29950727%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Daniel Nava-Rodrigues

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29950727%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

David Dolling

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29950727%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Tommaso Prayer-Galetti

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29950727%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Ana Ferreira

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29950727%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Antonio Esposito

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29950727%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Simon Barry

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29950727%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Wei Yuan

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29950727%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Maryou B Lambros

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29950727%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Carlo A Bravi

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29950727%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Alberto Briganti

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29950727%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

language of work or name

English

0 references

publication date

27 June 2018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29950727%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29950727%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

volume

559

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29950727%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

issue

7714

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29950727%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

page(s)

363-369

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29950727%20AND%20SRC:MED&resulttype=core&format=json

describes a project that uses

3 April 2020

ImageJ

1 reference

11 June 2022

https://www.ebi.ac.uk/europepmc/webservices/rest/PMC6461206/fullTextXML

inferred from PubMed Central ID database lookup

cites work

Global cancer statistics, 2012

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0266-0

7 January 2021

Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0266-0

7 January 2021

Antitumour activity of enzalutamide (MDV3100) in patients with metastatic castration-resistant prostate cancer (CRPC) pre-treated with docetaxel and abiraterone

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0266-0

7 January 2021

Exploring the Clinical Benefit of Docetaxel or Enzalutamide After Disease Progression During Abiraterone Acetate and Prednisone Treatment in Men With Metastatic Castration-Resistant Prostate Cancer.

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0266-0

7 January 2021

Clinical activity and tolerability of enzalutamide (MDV3100) in patients with metastatic, castration-resistant prostate cancer who progress after docetaxel and abiraterone treatment.

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0266-0

7 January 2021

Clinical activity of abiraterone acetate in patients with metastatic castration-resistant prostate cancer progressing after enzalutamide

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0266-0

7 January 2021

Enzalutamide in castration-resistant prostate cancer patients progressing after docetaxel and abiraterone

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0266-0

7 January 2021

Metastatic Prostate Cancer

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0266-0

7 January 2021

Prostate cancer progression after androgen deprivation therapy: mechanisms of castrate resistance and novel therapeutic approaches

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0266-0

7 January 2021

Reciprocal feedback regulation of PI3K and androgen receptor signaling in PTEN-deficient prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0266-0

7 January 2021

Microenvironmental regulation of tumor progression and metastasis

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0266-0

7 January 2021

B-cell-derived lymphotoxin promotes castration-resistant prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0266-0

7 January 2021

Bone morphogenetic protein-6 induces castration resistance in prostate cancer cells through tumor infiltrating macrophages

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0266-0

7 January 2021

Enhancing Chemotherapy Efficacy in Pten -Deficient Prostate Tumors by Activating the Senescence-Associated Antitumor Immunity

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0266-0

7 January 2021

Tumour-infiltrating Gr-1+ myeloid cells antagonize senescence in cancer.

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0266-0

7 January 2021

Effective combinatorial immunotherapy for castration-resistant prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0266-0

7 January 2021

Myeloid-derived suppressor cells as regulators of the immune system

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0266-0

7 January 2021

Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0266-0

7 January 2021

TLR9-Targeted STAT3 Silencing Abrogates Immunosuppressive Activity of Myeloid-Derived Suppressor Cells from Prostate Cancer Patients

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0266-0

7 January 2021

The role of myeloid cells in the promotion of tumour angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0266-0

7 January 2021

A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0266-0

7 January 2021

Diverse genetic-driven immune landscapes dictate tumor progression through distinct mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0266-0

7 January 2021

PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity.

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0266-0

7 January 2021

Diverse targets of the transcription factor STAT3 contribute to T cell pathogenicity and homeostasis.

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0266-0

7 January 2021

Discovery and biology of IL-23 and IL-27: related but functionally distinct regulators of inflammation

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0266-0

7 January 2021

IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0266-0

7 January 2021

ROR-γ drives androgen receptor expression and represents a therapeutic target in castration-resistant prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0266-0

7 January 2021

A Review of Biologic Therapies Targeting IL-23 and IL-17 for Use in Moderate-to-Severe Plaque Psoriasis

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0266-0

7 January 2021

A Phase 2 Trial of Guselkumab versus Adalimumab for Plaque Psoriasis

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0266-0

7 January 2021

Differential side effects profile in patients with mCRPC treated with abiraterone or enzalutamide: a meta-analysis of randomized controlled trials.

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0266-0

7 January 2021

Clinical significance of circulating interleukin-23 as a prognostic factor in breast cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0266-0

7 January 2021

Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0266-0

7 January 2021

IL-23 suppresses innate immune response independently of IL-17A during carcinogenesis and metastasis

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0266-0

7 January 2021

Elements of cancer immunity and the cancer-immune set point

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0266-0

7 January 2021

Early evidence of anti-PD-1 activity in enzalutamide-resistant prostate cancer.

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0266-0

7 January 2021

Tumor-induced tolerance and immune suppression depend on the C/EBPbeta transcription factor.

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0266-0

7 January 2021

Characterization of cytokine-induced myeloid-derived suppressor cells from normal human peripheral blood mononuclear cells

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0266-0

7 January 2021

Integrative clinical genomics of advanced prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0266-0

7 January 2021

TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0266-0

7 January 2021

Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0266-0

7 January 2021

Organoid culture systems for prostate epithelial and cancer tissue.

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0266-0

7 January 2021

Interleukin 6 activates androgen receptor-mediated gene expression through a signal transducer and activator of transcription 3-dependent pathway in LNCaP prostate cancer cells

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/29950727

12 December 2020

inferred from PubMed ID database lookup

Erratum: Corrigendum: ROR-γ drives androgen receptor expression and represents a therapeutic target in castration-resistant prostate cancer

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/29950727

12 December 2020

inferred from PubMed ID database lookup

Metastatic Prostate Cancer

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/29950727

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1038/S41586-018-0266-0

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29950727%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29950727%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

PubMed publication ID

29950727

1 reference